Human herpes simplex virus: Life cycle and development of inhibitors

@article{Kukhanova2014HumanHS,
  title={Human herpes simplex virus: Life cycle and development of inhibitors},
  author={Marina K Kukhanova and Anna N Korovina and Sergey N. Kochetkov},
  journal={Biochemistry (Moscow)},
  year={2014},
  volume={79},
  pages={1635 - 1652}
}
WHO reports that 90% of human population is infected by different types of herpesviruses, which develop latency or cause oral and genital herpes, conjunctivitis, eczema herpeticum, and other diseases. Herpesvirus almost always accompanies HIV-infection and complicates AIDS treatment. Herpes simplex virus type 1 is one of the most wide spread viruses from the Herpesviridae family. HSV virion, genome structure, replication mechanisms, antiherpes drug development strategies, including design of… 

Herpesvirus Polymerase Inhibitors

Experimental Dissection of the Lytic Replication Cycles of Herpes Simplex Viruses in vitro

The lytic replication cycles of herpes simplex viruses are reviewed and dissected, discussing key steps involved in cell infection and the processes that yield new virions to facilitate the identification of the mechanisms of action of anti-HSV compounds.

Current and Emerging Therapies for Ocular Herpes Simplex Virus Type-1 Infections

The lifecycle of HSV-1 as it pertains to corneal infections and the clinically approved as well as emerging treatments to combat HSV1 infections are discussed and some newly identified host targets for the antiviral drug development are highlighted.

Herpesvirus: an underestimated virus

This short review proposes to present concisely the history of HSV, its taxonomy, physical structure, and replication and to explore the pathogenesis of the infection, clinical manifestations, laboratory diagnosis, treatment, prophylaxis and epidemiology of the diseases.

Herpes Simplex Virus: Methods and Protocols

This book provides protocols currently in use in leading laboratories in many fields of HSV-1 research, covering basic aspects of virus structure, the prevalence of and diseases caused by the virus, replication in cultured cells, viral latency, antiviral defenses, and the mechanisms that the virus uses to counteract these defenses.

Herpes Simplex Virus Establishment, Maintenance, and Reactivation: In Vitro Modeling of Latency

Cell culture models that recapitulate latent infection provide valuable insight on the host processes regulating viral establishment and maintenance of latency in herpes simplex viruses.

Tour de Herpes: Cycling Through the Life and Biology of HSV-1.

This book provides protocols currently in use in leading laboratories in many fields of HSV-1 research, covering basic aspects of virus structure, the prevalence of and diseases caused by the virus, replication in cultured cells, viral latency, antiviral defenses, and the mechanisms that the virus uses to counteract these defenses.

Ginkgolic Acid Inhibits Herpes Simplex Virus Type 1 Skin Infection and Prevents Zosteriform Spread in Mice

Ginkgolic acid’s antiviral activity against HSV-1 skin infection in BALB/cJ mice is reported and it is anticipated it to be effective against additional cutaneous and potentially systemic viral infections.

Medicinal plants and natural compounds against acyclovir-resistant HSV infections

This review summarized the plant extracts and natural compounds that inhibited ACV-resistant HSV infection and their mechanism of action.

Harringtonine Inhibits Herpes Simplex Virus Type 1 Infection by Reducing Herpes Virus Entry Mediator Expression

Harringtonine showed antiviral activity against HSV-1 and ACV-resistant strains by targeting HVEM and could be a promising therapeutic candidate for mitigating HSv-1-induced-pathogenesis.
...